A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver. Read more about A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver.
Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex. Read more about Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex.
Discrete spatial organization of TGFβ receptors couples receptor multimerization and signaling to cellular tension. Read more about Discrete spatial organization of TGFβ receptors couples receptor multimerization and signaling to cellular tension.
The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. Read more about The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration.
LynA regulates an inflammation-sensitive signaling checkpoint in macrophages. Read more about LynA regulates an inflammation-sensitive signaling checkpoint in macrophages.
Developmental compartments in the larval trachea of Drosophila. Read more about Developmental compartments in the larval trachea of Drosophila.
An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish. Read more about An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish.
Mapping the conformational landscape of a dynamic enzyme by multitemperature and XFEL crystallography. Read more about Mapping the conformational landscape of a dynamic enzyme by multitemperature and XFEL crystallography.
Molecular architecture of the yeast Mediator complex. Read more about Molecular architecture of the yeast Mediator complex.
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits. Read more about Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits.
